MyFinsight

HomeCompareAbout

MyFinsight

Making company financials insightful for everyone

  • About
  • Privacy Policy
  • Contact

Follow Us

  • Thread
  • X.com
  • Instagram

© 2026 MyFinsight. All rights reserved.

Recent SEC Filings
10/2NIKE, Inc.(NKE)10/2DARDEN RESTAURANTS INC(DRI)9/30CONAGRA BRANDS INC.(CAG)9/29Carnival Corp Ltd.(CCL)9/29URANIUM ENERGY CORP(UEC)9/29COPART INC(CPRT)9/24BLACKBERRY Ltd(BB)9/24PAYCHEX INC(PAYX)9/23GENERAL MILLS INC(GIS)9/22ADOBE INC.(ADBE)9/18KROGER CO(KR)10/2NIKE, Inc.(NKE)10/2DARDEN RESTAURANTS INC(DRI)9/30CONAGRA BRANDS INC.(CAG)9/29Carnival Corp Ltd.(CCL)9/29URANIUM ENERGY CORP(UEC)9/29COPART INC(CPRT)9/24BLACKBERRY Ltd(BB)9/24PAYCHEX INC(PAYX)9/23GENERAL MILLS INC(GIS)9/22ADOBE INC.(ADBE)9/18KROGER CO(KR)

UPEXI, INC. (UPXI)

UPEXI, INC. (UPXI)

||
||

Cash Flow Overview

Change in Cash
$2,803,436
Free Cash flow
-$21,000,209
Unit: Dollar
Positive Cash Flow Breakdown
    • Unrealized loss (gain) on digita...
    • Proceeds from issuance of common...
    • Digital asset revenue conversion...
    • Others
Negative Cash Flow Breakdown
    • Net loss
    • Acquisition of digital assets
    • Digital asset revenue
    • Others
Cash Flow
2026-06-30
2025-06-30
Digital asset revenue
-
985,009
Loss on impairment of building
-
0
Impairment of goodwill and intangible assets
-
0
Net loss from operations
-
-13,684,209
Net loss
-246,064,698
-
Depreciation and amortization
456,249
757,758
Unrealized loss (gain) on digital assets
-195,059,336
-
Realized loss on sale of digital assets
6,773,418
-
Unrealized (gain) loss on digital assets
-
101,332
Digital asset revenue
17,429,206
-
Gain on the sale of vitamedica and income from discontinued operations
-
0
Digital asset revenue conversion to usd
13,192,785
-
Loss on the sale of new england technology
-
0
Realized loss on digital asset revenue conversion to usd
4,931,791
-
Amortization of loan costs
3,655,535
30,462
Loss on disposal of property and equipment
-237,727
-
Amortization of consideration discount
-
0
Gain on extinguishment of debt
10,288,342
-
Inventory write-off
0
748,874
Loss on sale of assets related to relocation of facility
-
0
Gain on sale of interactive offers
-
0
Loss on the disposal of assets
-
-10,743
Bad debt reserve for amazon receivable
0
933,950
Reduction of acquisition payable
0
152,500
Lease impairment (gain on settlement)
0
-
Impairment on assets from manufacturing shut down
1,422,289
-
Impairment on acquired intangible assets
750,000
-
Issuance of stock for services
0
250,000
Lease impairment (gain on settlement)
-
269,994
Change in deferred tax asset
-
0
Stock-based compensation
21,895,814
2,106,862
Accounts receivable
-60,271
484,580
Inventory
-886,909
470,188
Prepaid expenses and other assets
411,616
-222,005
Operating lease payable
-26,667
20,965
Accounts payable and accrued liabilities
3,950,834
2,865,251
Deferred revenue
-8,636
-222,100
Net cash provided by operating activities - continuing operations
-
-8,423,042
Net cash provided by (used in) operating activities - discontinued operations
-
0
Net cash used in operating activities
-20,956,207
-8,423,042
Proceeds from the sale of building
0
4,005,516
Proceeds from the sale of e-core
0
2,000,000
Proceeds from the sale of mw products assets
175,000
-
Proceeds from the sale of vitamedica, inc
2,000,000
0
Proceeds from the sale of interactive offers, net of liabilities paid
-
0
Acquisition of digital assets
40,035,365
-
Acquisition and sale of digital assets, net
-
104,910,839
Proceeds from the sale of digital assets
8,030,606
-
Acquisition of cygnet online llc, net
-
0
Acquisition of royalty interest
750,000
-
Acquisition of property and equipment
44,002
387,760
Net cash provided by (used in) investing activities - continuing operations
-
-99,293,083
Net cash (used in) investing activities - discontinued operations
-
0
Net cash used in investing activities
-30,623,761
-99,293,083
Proceeds from issuance of common stock
75,158,289
92,556,053
Issuance of preferred stock series a
0
325,000
Proceeds from exercise of warrants
107,889
250,000
Repurchases of common stock
2,773,959
-
Proceeds from short-term treasury debt
5,000,000
20,000,000
Repayment of short-term treasury debt
10,400,000
-
Proceeds from issuance of convertible notes
0
350,000
Repayment of promissory notes
560,000
-
Proceeds from related party advance
0
75,000
Repayment of related party advance
0
175,000
Payments of equity issuance costs
4,519,873
-
Payments of debt issuance costs
7,628,942
-
Payment on acquisition notes payable
-
-66,655
Payment on acquisition notes payable
0
500,000
Payment on convertible note
0
150,000
Repayment on note payable on building
-
2,634,538
Proceeds from issuance of short-term debt
0
-
Net cash used in financing activities - continuing operations
-
110,029,860
Repayment of related party note payable
0
-
Net cash (used in) provided by financing activities - discontinued operations
-
0
Repayment on note payable on building
0
-
Net cash provided by financing activities
54,383,404
110,029,860
Net increase in cash
2,803,436
2,313,735
Effect of exchange rate changes on cash
-
0
Cash, beginning of period
2,975,150
661,415
Cash, end of period
5,778,586
2,975,150
Unit: Dollar.

Time Plot

Show the time plot by selecting a row from the table.

Cash Flow

UPXI Cash Flow Sankey DiagramSankey diagram visualizing UPXI cash flow for the periodProceeds from issuance ofcommon stock$75,158,289 (-18.80%↓ Y/Y)Proceeds from short-termtreasury debt$5,000,000 (-75.00%↓ Y/Y)Proceeds from exercise ofwarrants$107,889 (-56.84%↓ Y/Y)Net cash provided byfinancing activities$54,383,404 (-50.57%↓ Y/Y)Canceled cashflow$25,882,774 Net increase in cash$2,803,436 (21.16%↑ Y/Y)Canceled cashflow$51,579,968 Repayment of short-termtreasury debt$10,400,000 Payments of debt issuancecosts$7,628,942 Payments of equityissuance costs$4,519,873 Repurchases of common stock$2,773,959 Repayment of promissorynotes$560,000 Proceeds from the sale ofdigital assets$8,030,606 Proceeds from the sale ofvitamedica, inc$2,000,000 Proceeds from the sale ofmw products assets$175,000 Unrealized loss (gain) ondigital assets-$195,059,336 Stock-based compensation$21,895,814 (939.26%↑ Y/Y)Digital asset revenueconversion to usd$13,192,785 Realized loss on sale ofdigital assets$6,773,418 Realized loss on digitalasset revenue...$4,931,791 Accounts payable andaccrued liabilities$3,950,834 (37.89%↑ Y/Y)Amortization of loan costs$3,655,535 (11900.31%↑ Y/Y)Impairment on assets frommanufacturing shut down$1,422,289 Inventory-$886,909 (-288.63%↓ Y/Y)Impairment on acquiredintangible assets$750,000 Depreciation andamortization$456,249 (-39.79%↓ Y/Y)Loss on disposal ofproperty and equipment-$237,727 Accounts receivable-$60,271 (-112.44%↓ Y/Y)Net cash used ininvesting activities-$30,623,761 (69.16%↑ Y/Y)Net cash used inoperating activities-$20,956,207 (-148.80%↓ Y/Y)Canceled cashflow$10,205,606 Canceled cashflow$253,272,958 Acquisition of digitalassets$40,035,365 Net loss-$246,064,698 Acquisition of royaltyinterest$750,000 Acquisition of property andequipment$44,002 (-88.65%↓ Y/Y)Digital asset revenue$17,429,206 (1669.45%↑ Y/Y)Gain onextinguishment of debt$10,288,342 Prepaid expenses andother assets$411,616 (285.41%↑ Y/Y)Operating lease payable-$26,667 (-227.20%↓ Y/Y)Deferred revenue-$8,636 (96.11%↑ Y/Y)